Visual function has classically been defined by Snellen acuity, supplemented by visual field testing. Indeed, our definitions of legal blindness are couched in terms of Snellen acuity level or visual field subtended. These subjective tests have served, as they are easy to standardise and require a minimum of instrumentation. They may perhaps be taken as measures of the 'quantity' of vision. More difficult to standardise, and until recently much more difficult to evaluate, are estimations of the 'quality' of vision. Parameters such as contrast sensitivity at different spatial frequencies (a modulation transfer function) would provide one perspective on this subject. The recently developed Arden gratings1 provide a practical clinical method of evaluating such visual sensitivity.
A person's visual perception of the world may be altered in various ways by disease states. Optic nerve and macular diseases lead to visual disturbances that are often (in optic nerve disease) or usually (in macular disease) not relevent to description in visual field terminology. Likewise, macular and optic nerve disturbances may lead to significant functional loss which is not accurately reflected by tests of high-contrast resolution such as Snellen optotypes.
Snellen optotypes, VER responses to alternating checkerboard stimuli, and Arden contrast sensitivity grating charts are not equivalent visual stimuli. (luminance) stimuli in order to elicit a recordable VER. The 3 intensities of luminance used, in increasing order of brightness, were 'on-off' (the entire television screen flashing on and off), and the S1 and S16 settings on the Grass PS22 photostimulator with the stimulating light placed 4 ft (1 2 m) from the subject. These light flash (luminance) VERs, while obviously not measuring precisely the same function as the constant-luminance pattern reversal VERs, were recorded and averaged in an identical manner; 128 transient responses obtained from a monopolar electrode placed 1 cm above the inion were averaged for each monocular recording.
Our patient sample included a variety of macular and optic nerve diseases. Among these were senile macular degeneration, macular dystrophies, cystoid macular oedema, premacular fibrosis, retrobulbar neuritis, ischaemic optic neuropathy, traumatic neuropathies, tumours, etc. Patients with significant medial opacities, for example, cataracts, corneal scars, etc., were excluded. Patients ranged in age from 8 to 86 years, 75% being between 40 and 80 years old.
Results
In general, Snellen acuity proved most resistant to degradation by less severe macular and optic nerve disease states. This familiar test, using test symbols intimately known to patients and presented for recognition in high contrast at the patient's own chosen rate of response, did not prove to be a good screening test for macular or optic nerve diseases.
VER responses to alternating high-contrast black and white checks, obviating need for conscious recognition, interpretation, or ability to use clues (for example, 'could be E, B, 0, or D, but certainly isn't L or P or T') were intermediate in sensitivity.
While Snellen acuity was sometimes more sensitive than VER acuity in macular diseases, 44% of examined patients showing relatively greater decrease in Snellen acuity (Fig. 1) , the VER was definitely a more sensitive test in optic nerve diseases, where 82% showed greater abnormality on VER testing (Fig. 2) . The superiority of the VER in comparison to Snellen testing in optic nerve disease has been shown by many investigators5-7 using delayed VER responses as the criterion of abnormality. The current study provides evidence that the same is true using loss of recordable VER responses to , and S16 on ordinate scale (Figs. 1, 2 , 5, and 6) refer to luminance VER stimuli (recordedfor patients in whom no detectable response was obtained to large check pattern-reversal stimuli). In this andfollowing figures the diagonal line runs from good acuity or score (lower left) to very poor acuity or score (upper right). 56% of data points lie above the diagonal, representing relatively greater degradation of VER acuity, while 44% (below the diagonal) show relatively greater fall-off in Snellen acuity. (Figs. 3 and 4) , the Arden test was equal to VER determinations in optic nerve disease (Fig. 5) and was easily superior to VER acuity as an early indicator of macular dysfunction, where 85% of patients showed relatively greater impairment of Arden score than reduction of VER acuity (Fig. 6) (Fig. 7) . Snellen acuity was 20/30 -2 OD, 20/60 OS. VER responses could be obtained to 5' checks with either eye. However, the lower contrast of the Arden gratings was completely nondiscernible with either eye (score of 150 OU).
'Denser' anatomical lesions such as the macular degenerations tended to affect VER acuity as well as Arden scores. For example, a 54-year-old male was 6 weeks after cataract extraction OS, with resolving cystoid macular oedema demonstrated by fluorescein angiography (Fig. 8) . Snellen acuity had improved to 20/25 +3. VER responses were small with 40' checks, and were nonrecordable with 20' checks. The Arden score was 123 (plates 6 and 7 were completely missed).
Focal foveal photoreceptor abnormalities would be expected to cause more interference with VER and Snellen acuities (both tests of resolution of macular targets) than with sinusoidally distributed VER stimuli may be varied almost infinitely with the aid of electronics. However, stimulating and recording with such apparatus is costly, elaborate, and relatively time-consuming, and is difficult to standardise between laboratories. Furthermore, in following diminishing responses to an end point, VER recordings are ambiguous regarding the presence or absence of small responses superimposed on the background 'noise', and extrapolations are often necessary. VER testing is simply too demanding of time, resources, and interpretation to be practical in the evaluation of large numbers of patients.
The determination of Snellen acuity possesses virtues beyond its ease of performance and universal familiarity. This test requires the subject to provide a correct answer, as opposed to the categorical Arden end point ('yes, I see it') . In following a disease process over time the patient anxious to please his doctor and do well can claim ability to discern the gratings before he actually can, while the Snellen letters require correct elucidation.
By varying stimulus size and contrast the Arden test has incorporated 2 of the major parameters one would be interested in evaluating with sophisticated VER stimulators. The Arden grating test should be easy to standardise, as the only variables are lighting and rate of exposure (presentation) of the test plates. One factor not noted by Arden is the age dependence of 'normal' scores8 (Fig. 10) , and this must be taken into account (as was done in the present study) when evaluating a subject ' 
